Clinical Trial Update: Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating human mesenchymal stem cells in infants at high risk for bronchopulmonary dysplasia (Phases 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Human Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Children's Hospital of Chongqing Medical University | Conditions: Bronchopulmonary Dysplasia | Phase 1, Phase 2 | Status: UNKNOWN